Back to search

Article

Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s Disease

2025-07-24

Abstract excerpt

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by cognitive decline, synaptic loss, and multifaceted pathology involving amyloid-β (Aβ) aggregation, tau hyperphosphorylation, neuroinflammation, and impaired proteostasis. In recent years, biologic therapies, such as monoclonal antibodies, vaccines, antisense oligonucleotides (ASOs), and gene therapies, have gained prominence as p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6bfe4c9a-735a-5701-99fb-fb8d0fb729b2
DOI
10.20944/preprints202507.2076.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s DiseaseDOI 10.20944/preprints202507.2076.v1
Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious UpdateSemantic proximity
Recent Insights into Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.Semantic proximity
Tau-Targeting Nanoparticles for Treatment of Alzheimer's DiseaseSemantic proximity
FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?Semantic proximity
Nanobody Therapeutics in Alzheimer’s Disease: From Molecular Mechanisms to Translational ApproachesSemantic proximity
The Alzheimer’s disease drug development landscapeSemantic proximity
A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Intracisternal Engineered Autologous Exosomes (NV-101) to Restore Neuronal Proteostasis in Early Alzheimer’s Disease: The RESTORE ProtocolSemantic proximity
Disease‐modifying therapies in Alzheimer's diseaseSemantic proximity
Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.Semantic proximity
mRNA vaccine platform demonstrates potent immunotherapeutic targeting of amyloid-β and tau pathologies in Alzheimer's diseaseSemantic proximity
Molecular Therapeutics in Development to Treat Alzheimer’s DiseaseSemantic proximity
Targeting Alzheimer's disease with gene and cell therapiesSemantic proximity
Select a neighboring publication to make it the new centre.